Immunosuppression mediated by enzymes that degrade tryptophan by Van Den Eynde, B

AHR and tryptophan metabolism: a collaborative dynamics of immune regulation by Zhu, J, Van den Eynde, B

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism by Zhu, J, Petit, P, Van Den Eynde, B

Learning from the proteasome: how to fine-tune cancer immunotherapy by Vigneron, N, Abi Habib, J, Van den Eynde, B

Integrating next-generation dendritic Cell vaccines into the current cancer immunotherapy landscape. by Garg, A, Coulie, P, Van den Eynde, B, Agostinis, P

Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937 by Hoffmann, D, Pilotte, L, Stroobant, V, Van Den Eynde, B

Cytosolic processing governs TAP-independent presentation of a critical melanoma antigen by Vigneron, N, Ferrari, V, Van Den Eynde, B, Cresswell, P, Leonhardt, R

Production of spliced peptides by the proteasome by Vigneron, N, Stroobant, V, Ferrari, V, Abi Habib, J, Van den Eynde, B

Peptide splicing by the proteasome. by Vigneron, N, Ferrari, V, Stroobant, V, Abi Habib, J, Van den Eynde, B

IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids: Wakayin and Tsitsikammamines by Levy, T, Marchand, L, Stroobant, V, Pilotte, L, Van den Eynde, B, Rodriguez, F, Delfourne, E

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. by Hennequart, M, Pilotte, L, Cane, S, Hoffmann, D, Stroobant, V, Plaen, E, Van den Eynde, B

The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model by Krendyukov, A, Kneisel, N, Zhu, J, Merz, C, Richards, D, Gieffers, C, Van Den Eynde, B

Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging by Henrottin, J, Lemaire, C, Egrise, D, Zervosen, A, Van Den Eynde, B, Plenevaux, A, Franci, X, Goldman, S, Luxen, A

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors by Schramme, F, Crosignani, S, Frederix, K, Hoffmann, D, Pilotte, L, Stroobant, V, Preillon, J, Driessens, G, Van Den Eynde, B

Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β by Galant, C, Marchandise, J, Stoenoiu, MS, Ducreux, J, De Groof, A, Pirenne, S, Van Den Eynde, B, Houssiau, FA, Lauwerys, BR

The vacuolar pathway of long peptide cross-presentation can be TAP dependent by Ma, W, Stroobant, V, Heirman, C, Sun, Z, Thielemans, K, Mulder, A, Van Der Bruggen, P, Van Den Eynde, B

Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase by Kozlova, A, Thabault, L, Dauguet, N, Deskeuvre, M, Stroobant, V, Pilotte, L, Liberelle, M, Van den Eynde, B, Frédérick, R

Microenvironment tumor metabolic interactions highlighted by qMSI: Application to the tryptophan-kynurenine pathway in immuno-oncology by Ait-Belkacem, R, Bol, V, Hamm, G, Schramme, F, Van Den Eynde, B, Poncelet, L, Pamelard, F, Stauber, J, Gomes, B

Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase by Kozlova, A, Thabault, L, Liberelle, M, Klaessens, S, Prévost, JRC, Mathieu, C, Pilotte, L, Stroobant, V, Van den Eynde, B, Frédérick, R

Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes by Zhu, J, Powis de Tenbossche, C, Cané, S, Colau, D, van Baren, N, Lurquin, C, Schmitt-Verhulst, A, Liljeström, P, Uyttenhove, C, Van den Eynde, B